| P/E (FY) | — | Sales (TTM) | $151.9M |
| Earnings (TTM) | -$37.1M | ROE | −155.73% |
| Net Margin | −26.11% | ROIC | — |
| Debt / Equity | 2.94 | TD / EBITDA | — |
| EPS Growth 3Y | — | Sales Growth 3Y | 31.68% |
| Market Cap | $130.1M | Trading Days | 2025 |
| 52W High | 4.85 |
| 52W Low | 0.80 |
| % Off High | −61.44% |
| YTD | 35.51% | 1Y | −58.63% |
| 3Y | −5.08% | 5Y | −85.74% |
| Since incept. (ann.) | −28.39% |
Service 58% · Product 42%
| Ann. Volatility (1Y) | 107.44% | Ann. Volatility (3Y) | 108.47% |
| Sharpe (1Y) | −0.31 | Sharpe (3Y) | 0.55 |
| Max Drawdown (1Y) | −74.68% | Max Drawdown (3Y) | −87.33% |
| Beta (3Y, vs SPY) | 1.41 |
| Ticker | Name | Mkt cap | P/E |
|---|---|---|---|
| CVRX | CVRx, Inc. | $131.4M | — |
| RCEL | AVITA Medical, Inc. | $141.9M | — |
| GUTS | FRACTYL HEALTH, INC. | $114.6M | — |
| MBOT | Microbot Medical Inc. | $112.8M | — |
| APYX | Apyx Medical Corp | $161.6M | — |
| PDEX | PRO DEX INC | $179.9M | 21.1 |
| KRMD | KORU Medical Systems, Inc. | $184.2M | — |
| LUCD | Lucid Diagnostics Inc. | $185.7M | — |
| SKIN | SkinHealth Systems Inc. | $90.5M | — |
| INFU | InfuSystem Holdings, Inc | $200.2M | 32.0 |
| ANIK | Anika Therapeutics, Inc. | $201.6M | — |
| EMBC |
| Embecta Corp. |
| $213.0M |
| 2.2 |
